Estrogen Receptor-negative Breast Cancer Recruiting Phase 2 Trials for Palbociclib (DB09073)

IndicationStatusPhase
DBCOND0028543 (Estrogen Receptor-negative Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01037790PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCERTreatment